Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 7 February 2015, Vol 294, No 7848

Sort by: Newest first Oldest first A-Z Z-A

  • Fat-burning diet pills Subscription

    30 JAN 2015 16:32

    23 January 2015: A number of BBC News outlets reported on the use of fat-burning diet pills, bought legally from health shops and sometimes gyms. Jayne Lawrence, RPS chief scientist, was interviewed about the possible dangers of taking these supplements. Jayne spoke to BBC radio stations in Lincolnshire, Bristol, West Midlands, Shropshire, Newcastle and Humberside, as well as BBC Look North.

  • Wednesday 4 March: Aberdeen Subscription

    30 JAN 2015 16:30

    Local practice forum event, ’Foundation Years Celebration’. Riverside East, Robert Gordon University, Garthdee Road, Aberdeen AB10 7QB. Event 7.15pm, buffet 6.30pm. Contact b.addison@rgu.ac.uk to join by webinar. Book to attend event via RPS website.

  • Researchers dispute analysis that finds oseltamivir (Roche's Tamiflu) cuts flu symptoms by a day

    Tamiflu shortens flu symptoms by a day, study finds Subscription

    30 JAN 2015 14:45 By Ingrid Torjesen

    Oseltamivir (Roche’s Tamiflu) shortens the duration of flu symptoms by approximately a day, in infected patients, according to an analysis published in The Lancet.

  • Apremilast, an oral drug for psoriasis conditions, has been approved by the European Commission. Psoriasis (pictured) is an autoimmune disease

    First-in-class oral drug approved for psoriasis conditions in Europe Subscription

    30 JAN 2015 12:46 By Joanna Lyford
    Comments (1)

    The European Commission has authorised apremilast (Celgene’s Otezla), a first-in-class oral drug for the treatment of chronic plaque psoriasis and psoriatic arthritis in patients who have failed first-line systemic therapies.

  • John Moran dies Subscription

    30 JAN 2015 11:45

    On 15 January 2015, John Moran MRPharmS, aged 63, of 28 Goose Lane, Wickersley, Rotherham S66 1JS. Mr Moran registered with the Society in 1973.

  • Susan Dawn Hawker dies Subscription

    30 JAN 2015 11:45

    On 26 January 2015, Susan Dawn Hawker MRPharmS, aged 49, of Low Gelt Barn, Low Gelt, Brampton, Cumbria CA8 1SY. Mrs Hawker registered with the Society in 1988.

  • Dementia link to common medicines Subscription

    30 JAN 2015 11:45

    28 January 2015: A report was published which links commonly used medicines, including some over-the-counter treatments, to dementia. RPS English pharmacy board chair David Branford was interviewed by LBC Radio and Channel 5 News.

  • Wednesday 25 February: SW Scotland Subscription

    30 JAN 2015 11:44

    Local practice forum event, ‘Sale of P medicines: would you and your staff pass the Which? mystery shopper test and GPhC Premises Standards Inspection?’ In collaboration with the University of Aberdeen. Creebridge House Hotel, Minnigaff, Newton Stewart, Wigtownshire, Dumfries and Galloway DG8 6NP. Member-only event with invited staff. Event 7pm–9pm, buffet 6.15pm. Book via the South West Scotland LPF website.

  • Thursday 26 February: SW Scotland Subscription

    30 JAN 2015 11:40

    Local practice forum event, ’Sale of P medicines: would you and your staff pass the Which? mystery shopper test and GPhC Premises Standards Inspection?’ In collaboration with the University of Aberdeen. Gailes Hotel, Marine Drive, Irvine, Ayrshire KA11 5AE

  • Tuesday 17 February: South Yorkshire and Humber Subscription

    30 JAN 2015 11:38

    Local practice forum event, ’Update on COPD’. Oaklands Hall Hotel, Barton Street, Laceby, Grimsby DN37 7LF. Event 6.45pm for 7.30pm start. Book via sec2015@dashlpf.org.uk.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.